{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{product.productLabel}} {{product.model}}
{{#if product.featureValues}}{{product.productPrice.formattedPrice}} {{#if product.productPrice.priceType === "PRICE_RANGE" }} - {{product.productPrice.formattedPriceMax}} {{/if}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
Result display time: 17 min
Sample volume: 0.1 ml
... an aid in the diagnosis in patients suspicious for congestive heart failure, the detection left ventricular dysfunction of and in the assessment of the severity of congestive heart failure ...
... plasma and whole blood. It is used as an aid in the diagnosis of heart failure and its prognosis. For in vitro diagnostic use only. For professional use only. TEST PRINCIPLE This ...
Result display time: 100 min
Sample volume: 0.1 ml
Specificity: 95 % - 95 %
... indicator for corresponding heart failure. The concentration of fNT-proBNP in the blood is related to the severity of the disease. Therefore, NT-proBNP can not only assess the severity of acute and ...
Result display time: 10 min
Sample volume: 0.1 ml
... detection indicator for corresponding heart failure. The concentration of cNT-proBNP in the blood is related to the severity of the disease. Therefore, NT-proBNP can not only assess the severity of acute ...
Result display time: 5 min
Specificity: 55 %
Sensitivity: 81 %
... the potential role of NGAL as a biomarker in cardiovascular diseases. In an atherosclerosis model of heart disease, NGAL mRNA expression was upregulated as compared to control mice. In ...
Result display time: 5 min
Specificity: 60 %
Sensitivity: 80 %
Firalis MMP-9 ELISA kit is intended to be used for the in vitro quantification of human MMP-9 in human EDTA plasma samples as an aid for diagnosis of the risk of heart failure ...
Sample volume: 0.05, 0.025 ml
... C-reactive protein (CRP), PCT, IL6, etc. Besides, these inflammatory markers are often used in the fields of atherosclerosis, heart failure, rheumatoid, chronic obstructive pneumonia, tumor prognosis ...
... Fluorescence immunoassay MPO POCT Kit is used for the quantitative detection of myeloperoxidase (MPO) concentration in human plasma. Suitable for screening and auxiliary diagnosis of coronary heart disease. Summary The ...
NT-proBNP Test Kit (Dry Fluorescence Immunoassay) is intended for in-vitro quantitative measurement of NTproBNP (N-terminal Brain Natriuretic Peptide Precursor) in human serum and plasma. NT-proBNP can ...
Lansion Biotechnology Co., Ltd
Result display time: 70 min
... enteritis, enterocolitis, diarrhea, hematemesis, heart failure, etc. The Human Cytomegalovirus DNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) is an in vitro ...
Result display time: 8 min
... Diagnosis and exclusion of heart failure Risk strarification of acute coronary syndrome Detection of early and mild cardiac insufficiency Differential diagnosis of dyspnea Prognosis ...
Result display time: 12 min
... Indication Acute Heart failure, Congestive Heart Failure BNP levels are simple and objective measures of cardiac function. These measurements can ...
Please specify:
Help us improve:
remaining